CHD CHURCH & DWIGHT CO INC /DE/ Insider Trading

Director Ravichandra Krishnamurty Saligram sold 12,960 shares of CHD at $98.00 (–48.7% of holdings; 13,652 remain after).

Saligram sold approximately half his non-derivative shareholding in Church & Dwight on 2026-06-10 at $98.00, reducing his direct holdings from 26,612 to 13,652 shares. His prior three measurable sales at CHD (2025-05-30, 2024-12-16, 2024-06-04) produced mixed outcomes: two of the three showed negative 90-day returns, suggesting some pattern of well-timed exits at this ticker, though the most recent sale (May 2025) saw CHD decline 7.0% over 90 days while an earlier December 2024 sale actually preceded a 2.8% gain. At current price $97.78, the stock is 7.8% below its 52-week high ($106.04) and has moved +4.6% over the last 30 days. Church & Dwight trades at a P/E of 31.64 on $1.5B in latest-quarter revenue and $216.3M net income, with annual revenue growth of +1.6%—a modest growth profile relative to valuation. The sale's strategic rationale is not disclosed in public filings; investors should monitor whether subsequent CHD fundamentals or insider activity provide additional context.

Director Vergis Janet S. sells 12,960 shares of CHD at $101.00; holdings reduced 43.1% to 17,102 shares.

Director Vergis Janet S. sold 12,960 shares (13.0K shares) of Church & Dwight Co Inc at $101.00 on 2026-02-04, reducing her stake from 30,062 shares to 17,102 shares (a 43.1% reduction in holdings). This represents a material reduction in personal position rather than a routine trim. The sale occurred near the 52-week high of $113.20 (current price $100.60 is 11.1% below that peak), and the company's 30-day and 90-day price momentum show gains of 17.6% and 15.8% respectively, indicating positive recent performance. With a P/E of 30.86 and recent quarterly net income of $182.2M on revenue of $1,585,600,000, the company exhibits solid profitability and growth, but the concentrated reduction in director holdings merits investor attention as a material change in inside ownership.

CEO Richard Dierker buys 5,470 CHD shares at $91.57; cluster buy by 2 other insiders within 14 days

Richard Dierker, President and CEO, purchased 5,470 shares on 2025-08-12 at $91.57, increasing his holdings by 25.2% to 27,212 shares total. The transaction occurs within a cluster: two other insiders bought CHD within the same 14-day window, which may signal coordinated management conviction. However, the stock has declined 5.9% over the past 30 days and 18.5% from its 52-week high of $113.20, trading below the purchase price at the current $92.25. Dierker's prior open-market history across all tickers shows mixed timing results: three prior buys averaged +4.7% 30-day returns but 0% 90-day win rate, while his same-ticker history at CHD shows two recent buys (May 2025) with similar short-term gains (+4.6%, +4.5%) that turned negative at the 90-day mark (−0.6%, −3.3%). The acquisition must be evaluated against CHD's elevated valuation (P/E of 42.71) and recent price momentum weakness.

CFO McChesney Lee B purchases 5,409 shares of CHD at $91.38; first position after zero holdings.

McChesney Lee B, EVP and CFO of Church & Dwight, executed an open-market purchase of 5,409 shares at $91.38 on 2025-08-08, establishing an initial position from zero prior holdings. The transaction occurred after a 19.0% decline from the 52-week high of $113.20 and a 6.5% decline over the preceding 30 days, though the stock remains above its 52-week low of $90.92. The company's fundamentals show revenue of $1,506,300,000.00 with net income of $191,000,000.00 in the latest quarter, and annual revenue growth of 4.1%. At a P/E of 42.44, the valuation remains elevated relative to historical ranges. As a first-time purchase by the CFO, this transaction establishes a measurable insider position but the modest size ($494,247.38) relative to the $22.3B market cap and absence of prior trading history at this ticker limits the informational content available from pattern analysis.

EVP Read Michael bought 2,000 CHD shares at $91.27; holdings rise 36.3% to 7,505 shares; prior same-ticker buys yielded +2.1–+7.6% over 90 days.

Michael Read, EVP International at Church & Dwight, purchased 2,000 shares (7.5K total post-transaction) on August 5, 2025, at $91.27 per share, adding $182.5K in capital. His four prior trades at CHD all resulted in positive 90-day returns ranging from +2.1% to +7.6%, and his cross-ticker track record shows 100% win rate over 90 days with +2.1% average return. The current market price of $92.50 is -18.3% from the 52-week high of $113.20 and down 6.2% over the trailing 30 days, suggesting the purchase occurred amid near-term weakness. This buy follows a historical pattern of well-executed accumulation at CHD with consistent positive 90-day outcomes, indicating the executive has a measured approach to adding position when the stock trades near its recent trading floor.

CCO Hooker Carlen sells 11,875 shares of CHD for $1,172,656.25, reducing stake 97.8%

Hooker Carlen, the company's Chief Commercial Officer, executed 3 separate sales on 2025-05-30 totaling 11,875 shares for $1,172,656.25 at $98.75 per share, reducing his post-transaction holdings to just 262 shares from 12,137 shares pre-transaction. This represents a 97.8% reduction in his equity position in Church & Dwight, a company with $1.5B in latest quarterly revenue and a $24.4B market cap. The transaction occurred when the stock was trading near recent levels (currently $99.04, +6.6% over 30 days but -10.5% over 90 days and -12.5% from its 52-week high of $113.20). The near-complete liquidation of a senior executive's holdings warrants scrutiny regarding his confidence in near-term company direction, though the transaction details themselves provide no stated rationale.

Director Saligram Ravichandra Krishnamurty sold 14,660 shares of CHD at $99.00, reducing holdings by 51.6%.

Saligram Ravichandra Krishnamurty sold 14,660 shares at $99.00 on 2025-05-30, reducing his holding from 28,407 shares to 13,747 shares—a 51.6% reduction. The stock is currently trading at $99.04, 12.5% below its 52-week high of $113.20 and up 6.6% over the past 30 days. Reviewing his prior open-market history across all tickers, his three prior sells averaged -2.3% return over 30 days and -1.3% over 90 days, with a 50.00% well-timed rate at the 90-day mark. At CHD specifically, his two prior sells with measurable outcomes (2024-12-16 and 2024-06-04) showed a 50% well-timed rate at 90 days, though the most recent sale on 2024-12-16 resulted in a +2.8% 90-day return (stock rose after the sale). This transaction does not follow a consistent pattern of well-timed exits at this ticker.

CHD CEO Dierker bought 13,334 shares for $1.3M across 3 transactions at blended avg $93.91; stock down 17.7% from 52-week high

Richard A Dierker, President and CEO, executed 3 separate open-market purchases totaling 13,334 shares for $1,252,214.00, expanding his holdings from 3,024 to 16,358 shares (+440.9% increase). The transactions were executed on 2025-05-13 and 2025-05-14 at prices ranging from $92.80 to $94.78, with a blended average of $93.91. The timing is notable: Church & Dwight stock currently trades at $93.16, down 11.8% over 30 days and 13.4% over 90 days, and stands 17.7% below its 52-week high of $113.20. Dierker's prior sales at CHD showed mixed 90-day outcomes (2 of 4 well-timed, average returns near flat), and his cross-ticker track record reveals limited predictive power (50% 90-day win rate on sells, -1.5% avg return). The large accumulation into a 39.64 P/E name amid recent price weakness warrants attention to whether management views the stock as attractive at these levels or whether other strategic considerations drive the timing.

Director Price Penry W sold 14,660 shares (14.7K) of CHD at $93.13 for $1.4M; holdings cut 35.2% to 27.0K shares.

Director Price Penry W executed a substantial reduction in CHD holdings, selling 14,660 shares at $93.13 and bringing his remaining position from 41,703 shares to 27,043 shares—a 35.2% decrease in stake. The transaction occurred at $93.13, while the current stock price stands at $91.57, down 10.2% over the past 30 days and 12.8% over 90 days from a 52-week high of $113.20. This sale represents a significant portfolio concentration decision by a director at a company with a P/E of 38.97 and $22.6B market capitalization. The magnitude of the holding reduction—more than one-third of his prior position—combined with the recent weakness in the stock price merits investor attention to whether this reflects broader operational or valuation concerns.

Read Michael (EVP, International) bought 3,000 shares of CHD at $92.07 on 2025-05-09, increasing holdings 119.8%.

Read Michael purchased 3,000 shares for $276,221.10, nearly doubling his stake from 2,505 to 5,505 shares. His cross-ticker track record shows 100.00% win rate at the 90-day mark, with 3 prior buys averaging +2.1% over 90 days. At CHD specifically, he has executed 3 prior buys (all on 2024-12-16), each showing +2.1% to +2.2% returns at 90 days, indicating a consistent pattern of well-timed entry points at this ticker. However, the stock currently trades at $91.57, down 19.1% from its 52-week high of $113.20 and down 10.2% over the past 30 days, suggesting this purchase enters during a period of weakness. The fundamentals show revenue of $1,467,100,000.00 with net income of $220,100,000.00 and 4.1% annual revenue growth, supporting a profitable business, though the elevated P/E of 38.97 may warrant attention given recent price declines.